Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach.

about

Clinicopathological and Prognostic Features of Surgical Management in Duodenal Gastrointestinal Stromal Tumors.Advances and Challenges on Management of Gastrointestinal Stromal Tumors.Gigantic GIST: A Case of the Largest Gastrointestinal Stromal Tumor Found to Date

P2860

Q47323711-B1991DA3-7675-4750-823D-765C80FB436F Q55263134-F2C7A6FA-458D-47EA-9E5D-C16C6B4C6E15 Q58603976-DF30CA82-71F2-4AEB-A488-4F0F01A04D21

P2860

Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach.

Item

http://www.wikidata.org/entity/Q41078856

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Phase II study of neoadjuvant ...... tromal tumours of the stomach.

@en

type

Item

label

Phase II study of neoadjuvant ...... tromal tumours of the stomach.

@en

prefLabel

Phase II study of neoadjuvant ...... tromal tumours of the stomach.

@en

P1476

Phase II study of neoadjuvant ...... tromal tumours of the stomach.

@en

P2093

Han-Kwang Yang

http://www.w3.org/2001/XMLSchema#string

Haruhiko Cho

http://www.w3.org/2001/XMLSchema#string

Hiroshi Honda

http://www.w3.org/2001/XMLSchema#string

Hyuk-Joon Lee

http://www.w3.org/2001/XMLSchema#string

Jeong-Hwan Yook

http://www.w3.org/2001/XMLSchema#string

Kazuhito Nabeshima

http://www.w3.org/2001/XMLSchema#string

Kyung Hee Lee

http://www.w3.org/2001/XMLSchema#string

Min-Hee Ryu

http://www.w3.org/2001/XMLSchema#string

Oh Kyoung Kwon

http://www.w3.org/2001/XMLSchema#string

Seiichi Hirota

http://www.w3.org/2001/XMLSchema#string

P2860

Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors.

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis

Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.

Downsizing treatment with tyrosine kinase inhibitors in patients with advanced gastrointestinal stromal tumors improved resectability.

Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.

P2888

bjc.2017.144

P304

25-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.2017.144

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085563077

http://www.w3.org/2001/XMLSchema#string

P698

28535156

http://www.w3.org/2001/XMLSchema#string

P932

5520207

http://www.w3.org/2001/XMLSchema#string

Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach.

about

P2860

P2860

Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932